FANCG Antibody

FANCG, involved in Fanconi anemia, confers resistance to both hygromycin and mitomycin C. FANCG contains a 5-prime GC-rich untranslated region characteristic of housekeeping genes. The putative 622-amino acid protein has a leucine-zipper motif at its N-terminus. Fanconi anemia is an autosomal recessive disorder with diverse clinical symptoms, including developmental anomalies, bone marrow failure, and early occurrence of malignancies. A minimum of 8 FA genes have been identified.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 2 applications: B/N, WB.

Showing Publications 1 - 5 of 5.

Publications using NB100-2566	Applications	Species
Jin L, Chun J, Pan C et al. MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEk Activation. Cancer Cell. 2018-07-09 [PMID: 30033091] (B/N)	B/N
Li N, Ding L, Li B et al. Functional Analysis of Fanconi Anemia Mutations in China. Exp. Hematol. 2018-07-18 [PMID: 30031030] (WB, Human)	WB	Human
Huang Y, Leung JW, Lowery M et al. Modularized functions of the Fanconi anemia core complex. Cell Rep 2014-06-26 [PMID: 24910428]
Wang Y, Leung JW, Jiang Y et al. FANCM and FAAP24 Maintain Genome Stability via Cooperative as Well as Unique Functions. Mol Cell 2013-01-16 [PMID: 23333308] (WB, Human)	WB	Human
Park, S et al. Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins. J Biol Chem;279(29):30053-9. 2004-07-16 [PMID: 15138265]

Array NB100-2566

• FANCG Antibodies
• FANCG Lysate
• FANCG Proteins